Global Genetically Engineered Animal Models & Services Market Growth (Status and Outlook) 2024-2030
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.
The global Genetically Engineered Animal Models & Services market size is projected to grow from US$ 2407.3 million in 2023 to US$ 3567 million in 2030; it is expected to grow at a CAGR of 5.8% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Genetically Engineered Animal Models & Services Industry Forecast” looks at past sales and reviews total world Genetically Engineered Animal Models & Services sales in 2023, providing a comprehensive analysis by region and market sector of projected Genetically Engineered Animal Models & Services sales for 2024 through 2030. With Genetically Engineered Animal Models & Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetically Engineered Animal Models & Services industry.
This Insight Report provides a comprehensive analysis of the global Genetically Engineered Animal Models & Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetically Engineered Animal Models & Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetically Engineered Animal Models & Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetically Engineered Animal Models & Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetically Engineered Animal Models & Services.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 232%.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetically Engineered Animal Models & Services market by product type, application, key players and key regions and countries.
Segmentation by type
Rats
Mice
Others
Segmentation by application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Horizon Discovery Group
Vitalstar Biotechnology
Please note: The report will take approximately 2 business days to prepare and deliver.